Immunopathogenesis of chronic obstructive pulmonary disease

Current Opinion in Pulmonary Medicine

Volumn 19, Issue 2, 2013, Pages 95-102

  Holloway, Rebecca A ^a   Donnelly, Louise E ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

CD4+ lymphocyte; CD8+ lymphocyte; macrophage; neutrophil

Indexed keywords

ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHEMOKINE; CIGARETTE SMOKE; CYTOKINE; GLUCOCORTICOID; MATRIX METALLOPROTEINASE; STEROID;

ADAPTIVE IMMUNITY; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CELL MIGRATION; CELL MOTILITY; CELL SURVIVAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE RELEASE; DISEASE COURSE; HOME OXYGEN THERAPY; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOPATHOGENESIS; INFLAMMATORY CELL; INNATE IMMUNITY; LEUKOCYTE; LYMPHOCYTE; MACROPHAGE; NEUTROPHIL; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHAGOCYTOSIS; PHENOTYPE; REVIEW; TH17 CELL; TREATMENT RESPONSE;

HUMANS; LEUKOCYTES; LUNG; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84873435354     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e32835cfff5     Document Type: Review

References (75)

1. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): A population-based prevalence study. Lancet 2007; 370:741-750
2. Mannino DM, Buist AS. Global burden of COPD: Risk factors, prevalence, and future trends. The Lancet 2007; 370:765-773
3. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD. http:// www goldcopd org/2011. [Accessed on 14 October 2012
4. Lindberg A, Eriksson B, Larsson LG, et al. Seven-year cumulative incidence of COPD in an age-Stratified general population sample. Chest 2006; 129:879-885
5. Owen CA. Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2008; 3:253-268
6. Nadel JA. Role of epidermal growth factor receptor activation in regulating mucin synthesis. Respir Res 2001; 2:85-89
7. Lams BE, Sousa AR, Rees PJ, Lee TH. Immunopathology of the small-Airway submucosa in smokers with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158:1518-1523
8. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-Airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350:2645-2653
9. Barnes PJ. Achieving asthma control. Curr Med Res Opin 2005; 21 SUPPL4:S5-S9
10. Barnes PJ. Inhaled corticosteroids in COPD: A controversy. Respiration 2010; 80:89-95
11. Garcha DS, Thurston SJ, Patel AR, et al. Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD. Thorax 2012; 67:1075-1080
12. Almansa R, Socias L, Andaluz-Ojeda D, et al. Viral infection is associated with an increased proinflammatory response in chronic obstructive pulmonary disease. Viral Immunol 2012; 25:249-253
13. Anderson HR, Spix C, Medina S, et al. Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: Results from the APHEA project. Eur Respir J 1997; 10:1064-1071
14. Donaldson GC, Goldring JJ, Wedzicha JA. Influence of season on exacerbation characteristics in patients with COPD. Chest 2012; 141: 94-100
15. Sethi S, Maloney J, Grove L, et al. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173:991-998
16. Barnes PJ. Macrophages as orchestrators of COPD. J COPD 2004; 1:50-70
17. Donnelly LE, Barnes PJ. Defective phagocytosis in airways disease. Chest 2012; 141:1055-1062
18. Berenson CS, Garlipp MA, Grove LJ, et al. Impaired phagocytosis of nontypeable Haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary disease. J Infect Dis 2006; 194:1375-1384
19. Taylor AE, Finney-Hayward TK, Quint JK, et al. Defective macrophage phagocytosis of bacteria in COPD. Eur Respir J 2010; 35:1039-1047
20. Hodge S, Hodge G, Scicchitano R, et al. Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunol Cell Biol 2003; 81:289-296
21. Hodge S, Hodge G, Brozyna S, et al. Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages. Eur Respir J 2006; 28:486-495
22. Hodge S, Reynolds PN. Low-Dose azithromycin improves phagocytosis of bacteria by both alveolar and monocyte-Derived macrophages in chronic obstructive pulmonary disease subjects. Respirology 2012; 17:802-807
23. Harvey CJ, Thimmulappa RK, Sethi S, et al. Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model. Sci Transl Med 2011; 3:78ra32
24. Malhotra D, Thimmulappa R, Vij N, et al. Heightened endoplasmic reticulum stress in the lungs of patients with chronic obstructive pulmonary disease: The role of Nrf2-regulated proteasomal activity. Am J Respir Crit Care Med 2009; 180:1196-1207
25. Malhotra D, Thimmulappa RK, Mercado N, et al. Denitrosylation of HDAC2 by targeting Nrf2 restores glucocorticosteroid sensitivity in macrophages from COPD patients. J Clin Invest 2011; 121:4289-4302
26. Barnes PJ, Adcock IM. Glucocorticoid resistance in inflammatory diseases. Lancet 2009; 373:1905-1917
27. Ito K, Ito M, Elliott WM, et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 2005; 352:1967-1976
28. Ito K, Yamamura S, Essilfie-Quaye S, et al. Histone deacetylase 2-Mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. J Exp Med 2006; 203:7-13
29. Winkler AR, Nocka KN, Williams CM. Smoke exposure of human macrophages reduces HDAC3 activity, resulting in enhanced inflammatory cytokine production. Pulm Pharmacol Ther 2012; 25:286-292
30. Mantovani A, Sica A, Locati M. Macrophage polarization comes of age. Immunity 2005; 23:344-346
31. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8:958-969
32. Shaykhiev R, Krause A, Salit J, et al. Smoking-Dependent reprogramming of alveolar macrophage polarization: Implication for pathogenesis of chronic obstructive pulmonary disease. J Immunol 2009; 183:2867-2883
33. Hodge S, Matthews G, Mukaro V, et al. Cigarette smoke-induced changes to alveolar macrophage phenotype and function are improved by treatment with procysteine. Am J Respir Cell Mol Biol 2011; 44:673-681
34. Kunz LI, Lapperre TS, Snoeck-Stroband JB, et al. Smoking status and antiinflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD. Respir Res 2011; 12:34
35. Stockley RA. Neutrophils and the pathogenesis of COPD. Chest 2002; 121:151S-155S.
36. Luo HR, Loison F. Constitutive neutrophil apoptosis: Mechanisms and regulation. Am J Hematol 2008; 83:288-295
37. Huizinga TW, van KF, Koenderman L, et al. The 40-kDa Fc gamma receptor (FcRII) on human neutrophils is essential for the IgG-induced respiratory burst and IgG-induced phagocytosis. J Immunol 1989; 142:2365-2369
38. Braber S, Thio M, Blokhuis BR, et al. An association between neutrophils and immunoglobulin free light chains in the pathogenesis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 185:817-824
39. Nakano T, Matsui M, Inoue I, et al. Free immunoglobulin light chain: Its biology and implications in diseases. Clin Chim Acta 2011; 412:843-849
40. Cohen G, Haag-Weber M, Mai B, et al. Effect of immunoglobulin light chains from hemodialysis and continuous ambulatory peritoneal dialysis patients on polymorphonuclear leukocyte functions. J Am Soc Nephrol 1995; 6:1592-1599
41. Paone G, Conti V, Vestri A, et al. Analysis of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patients. Dis Markers 2011; 31:91-100
42. Lucey EC, Goldstein RH, Stone PJ, Snider GL. Remodeling of alveolar walls after elastase treatment of hamsters. Results of elastin and collagen mRNA in situ hybridization. Am J Respir Crit Care Med 1998; 158:555-564
43. Gottlieb DJ, Stone PJ, Sparrow D, et al. Urinary desmosine excretion in smokers with and without rapid decline of lung function: The Normative Aging Study. Am J Respir Crit Care Med 1996; 154:1290-1295
44. Jackson PL, Xu X, Wilson L, et al. Human neutrophil elastase-Mediated cleavage sites of MMP-9 and TIMP-1: Implications to cystic fibrosis proteolytic dysfunction. Mol Med 2010; 16:159-166
45. Russell RE, Culpitt SV, DeMatos C, et al. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2002; 26:602-609
46. Masure S, Proost P, Van DJ, Opdenakker G. Purification and identification of 91-kDa neutrophil gelatinase. Release by the activating peptide interleukin-8. Eur J Biochem 1991; 198:391-398
47. Culpitt SV, Rogers DF, Traves SL, et al. Sputum matrix metalloproteases: Comparison between chronic obstructive pulmonary disease and asthma. Respir Med 2005; 99:703-710
48. Sinden NJ, Stockley RA. Proteinase 3 activity in sputum from subjects with alpha-1-Antitrypsin deficiency and COPD. Eur Respir J 2012. [Epub ahead of print
49. Kim D, Haynes CL. Neutrophil chemotaxis within a competing gradient of chemoattractants. Anal Chem 2012; 84:6070-6078
50. Sapey E, Stockley JA, Greenwood H, et al. Behavioral and structural differences in migrating peripheral neutrophils from patients with COPD. Am J Respir Crit Care Med 2011; 183:1176-1186
51. Saetta M, Baraldo S, Corbino L, et al. CD8ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160:711-717
52. Mikko M, Forsslund H, Cui L, et al. Increased intraepithelial (CD103) CD8 T cells in the airways of smokers with and without chronic obstructive pulmonary disease. Immunobiology 2012. [Epub ahead of print
53. Roos-Engstrand E, Ekstrand-Hammarstrom B, Pourazar J, et al. Influence of smoking cessation on airway T lymphocyte subsets in COPD. COPD 2009; 6:112-120
54. Shirai T, Suda T, Inui N, Chida K. Correlation between peripheral blood T-cell profiles and clinical and inflammatory parameters in stable COPD. Allergol Int 2010; 59:75-82
55. Hodge S, Hodge G, Ahern J, et al. Smoking alters alveolar macrophage recognition and phagocytic ability: Implications in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2007; 37:748-755
56. Zhu X, Gadgil AS, Givelber R, et al. Peripheral T cell functions correlate with the severity of chronic obstructive pulmonary disease. J Immunol 2009; 182:3270-3277
57. Paats MS, Bergen IM, Hoogsteden HC, et al. Systemic CD4 and CD8 T cell cytokine profiles correlate with GOLD stage in stable COPD. Eur Respir J 2011; 40:330-337
58. Barczyk A, Pierzchala W, Kon OM, et al. Cytokine production by bronchoalveolar lavage T lymphocytes in chronic obstructive pulmonary disease. J Allergy Clin Immunol 2006; 117:1484-1492
59. Freeman CM, Han MK, Martinez FJ, et al. Cytotoxic potential of lung CD8T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15. J Immunol 2010; 184:6504-6513
60. Kaur M, Smyth LJ, Cadden P, et al. T lymphocyte insensitivity to corticosteroids in chronic obstructive pulmonary disease. Respir Res 2012; 13:20
61. Agusti A, MacNee W, Donaldson K, Cosio M. Hypothesis: Does COPD have an autoimmune component? Thorax 2003; 58:832-834
62. Di Stefano A, Caramori G, Capelli A, et al. STAT4 activation in smokers and patients with chronic obstructive pulmonary disease. Eur Respir J 2004; 24:78-85
63. Cosio MG. Autoimmunity, T-cells and STAT-4 in the pathogenesis of chronic obstructive pulmonary disease. Eur Respir J 2004; 24:3-5
64. Ambrosi A, Espinosa A, Wahren-Herlenius M. IL-17: A new actor in IFNdriven systemic autoimmune diseases. Eur J Immunol 2012; 42:2274-2284
65. Vargas-Rojas MI, Ramirez-Venegas A, Limon-Camacho L, et al. Increase of Th17 cells in peripheral blood of patients with chronic obstructive pulmonary disease. Respir Med 2011; 105:1648-1654
66. Molet S, Hamid Q, Davoine F, et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 2001; 108:430-438
67. Chang Y, Nadigel J, Boulais N, et al. CD8 positive T cells express IL-17 in patients with chronic obstructive pulmonary disease. Respir Res 2011; 12:43
68. Pridgeon C, Bugeon L, Donnelly L, et al. Regulation of IL-17 in chronic inflammation in the human lung. Clin Sci 2011; 120:515-524
69. Siena L, Gjomarkaj M, Elliot J, et al. Reduced apoptosis of CD8 T-lymphocytes in the airways of smokers with mild/moderate COPD. Respir Med 2011; 105:1491-1500
70. Lee SH, Goswami S, Grudo A, et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med 2007; 13:567-569
71. Rinaldi M, Lehouck A, Heulens N, et al. Antielastin B-cell and T-cell immunity in patients with chronic obstructive pulmonary disease. Thorax 2012; 67:694-700
72. Ballarin A, Bazzan E, Zenteno RH, et al. Mast cell infiltration discriminates between histopathological phenotypes of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 186:233-239
73. Bafadhel M, McKenna S, Terry S, et al. Acute exacerbations of chronic obstructive pulmonary disease: Identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med 2011; 184:662-671
74. Liesker JJ, Bathoorn E, Postma DS, et al. Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD. Respir Med 2011; 105:1853-1860
75. Bafadhel M, McKenna S, Terry S, et al. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: A randomized placebo-controlled trial. Am J Respir Crit Care Med 2012; 186:48-55